Clinical Trial

ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF

Recruiting
View on ClinicalTrials.gov →
Summary
The artificial liver support system (ALSS) in patients with acute on chronic liver failure - the use of combined molecular adsorption system with double plasma (DPMAS) and therapeutic plasma exchange (TPE), its effect on primary coagulation, inflammation and the function of vital organs.
Trial Details
NCT Number NCT07329036
Lead Sponsor Institute for Clinical and Experimental Medicine
Conditions Acute Liver Failure
Enrollment 25 participants
Start Date 2024-04-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-09